Accessibility of Device-Aided Therapies for Persons With Parkinson's Disease in Poland.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS

ACS Applied Bio Materials Pub Date : 2024-04-01 Epub Date: 2023-11-20 DOI:10.14802/jmd.23172

Katarzyna Smilowska, Tomasz Pietrzykowski, K Ray Chaudhuri, Bastiaan R Bloem, Daniel J van Wamelen

{"title":"Accessibility of Device-Aided Therapies for Persons With Parkinson's Disease in Poland.","authors":"Katarzyna Smilowska, Tomasz Pietrzykowski, K Ray Chaudhuri, Bastiaan R Bloem, Daniel J van Wamelen","doi":"10.14802/jmd.23172","DOIUrl":null,"url":null,"abstract":"Objective: Access to care for people with Parkinson's disease (PD), particularly to device-aided therapies (DAT), is not equally distributed. The objective was to analyze accessibility to DAT (deep brain stimulation, intraduodenal levodopa pump therapy, and apomorphine pump therapy) in Poland.Methods: We analyzed the distribution of DAT use in Poland by determining the number of persons with PD receiving one of the three DATs during 2015-2021.Results: In 2021, the number of persons receiving DAT in Poland was 0.56% of the total PD population, increasing from 0.21% in 2015. Overall, deep brain stimulation was the preferred DAT in Poland, but strong regional differences in the use of the other DATs were observed. Accessibility to DAT was negatively associated with average annual income (p < 0.001).Conclusion: Access to DAT for persons with PD in Poland is still limited, and strong regional differences in accessibility were observed, although its general increase over the last decade is encouraging.","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":" ","pages":"208-212"},"PeriodicalIF":4.6000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082617/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14802/jmd.23172","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/11/20 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: Access to care for people with Parkinson's disease (PD), particularly to device-aided therapies (DAT), is not equally distributed. The objective was to analyze accessibility to DAT (deep brain stimulation, intraduodenal levodopa pump therapy, and apomorphine pump therapy) in Poland.

Methods: We analyzed the distribution of DAT use in Poland by determining the number of persons with PD receiving one of the three DATs during 2015-2021.

Results: In 2021, the number of persons receiving DAT in Poland was 0.56% of the total PD population, increasing from 0.21% in 2015. Overall, deep brain stimulation was the preferred DAT in Poland, but strong regional differences in the use of the other DATs were observed. Accessibility to DAT was negatively associated with average annual income (p < 0.001).

Conclusion: Access to DAT for persons with PD in Poland is still limited, and strong regional differences in accessibility were observed, although its general increase over the last decade is encouraging.

查看原文本刊更多论文

波兰帕金森病患者装置辅助疗法的可及性。

背景:帕金森氏病(PD)患者获得护理的机会，特别是器械辅助治疗(DAT)的机会分布并不均匀。目的:分析深部脑刺激的可及性;十二指肠内左旋多巴泵治疗;或阿帕吗啡泵疗法)。方法:我们通过确定2015-2021年期间接受三种DAT之一的PD患者数量，分析了波兰DAT使用的分布。结果:2021年波兰接受DAT治疗的人数占PD总人数的0.56%，比2015年的0.21%有所上升。总的来说，在波兰，脑深部刺激是首选的数据处理方法，但在其他数据处理方法的使用上存在强烈的地区差异。数据的可及性与平均年收入呈负相关(p结论:波兰PD数据的可及性仍然有限，可及性显示出强烈的区域差异，尽管在过去十年中其总体增长令人鼓舞。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ACS Applied Bio Materials Chemistry-Chemistry (all)

CiteScore

9.40

自引率

2.10%

发文量

464